| Lung Non-Small Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 313show all (up to 200) |
|---|
| → investigated in trials for | Carboplatinsmall molecule 557 trials (196 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 557 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall_molecule 493 trials (166 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 493 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 417 trials (196 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 417 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 378 trials (121 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 378 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 327 trials (93 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 327 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall_molecule 318 trials (76 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 318 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall_molecule 197 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 197 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 192 trials (71 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 192 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 183 trials (32 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 183 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 182 trials (35 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 182 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall_molecule 160 trials (88 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 160 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 148 trials (55 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 112 trials (33 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall_molecule 98 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 95 trials (43 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 77 trials (28 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 77 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 69 trials (18 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 69 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 64 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal_antibody 63 trials (23 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 61 trials (34 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall_molecule 59 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 52 trials (38 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall_molecule 49 trials (13 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 43 trials (16 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 43 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 42 trials (29 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 41 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 39 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 39 trials (16 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal_antibody 36 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 34 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall_molecule 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 28 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 27 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aumolertinibsmall molecule 26 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 25 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall_molecule 25 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal_antibody 24 trials (20 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 24 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 23 trials (21 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lazertinibsmall_molecule 23 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 22 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 21 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 18 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 17 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 16 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 15 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 14 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 14 trials (14 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunvozertinibsmall_molecule 12 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Necitumumabmonoclonal antibody 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall_molecule 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall_molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tepotinibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Divarasibsmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Poziotinibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall_molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rociletinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sevabertinibsmall_molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taxol 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Befotertinibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacomitinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Naquotinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taletrectinibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall_molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Repotrectinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Motesanibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinib Mesylatesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | TAK-788small molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zongertinibsmall_molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Conatumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pictilisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pilaralisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Doublet 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Pemetrexed Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Claturafenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mobocertinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |